Komori
Cyberdyne (7779) · RiskRestated

Risks of product defects, product liability and recalls

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2019.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20192016: 120162017: 120172018: 120182019: 12019
Same theme, other companies
Product and Sold-Product Quality Defect, Quality Assurance and Product Liability RiskA theme 713 companies write about · 742 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2026: 12 of 60 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 194 companies compared. The sentences above are computed from all 194.Comparing 200 of the theme's 742 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2019RestatedAnnual report

    「The Group continues to work to further improve product quality in accordance with ISO 13485, the international standard for quality management of medical devices. However, there is no guarantee that its products will remain free of defects or that costs associated with product liability claims, recalls or other matters will not arise in the future.」

    The company continues to disclose its efforts to improve quality under ISO 13485 and the risks of product defects, product liability and recalls.
  2. FY2018RestatedAnnual report

    「The Group continues to work to further improve product quality in accordance with ISO 13485, the international standard for quality management of medical devices. However, there is no guarantee that its products will remain free of defects or that costs associated with product liability claims, recalls or other matters will not arise in the future.」

    While describing its efforts to improve quality under ISO 13485, the company reiterates the possibility of product defects, product liability claims and recalls.
  3. FY2017RestatedAnnual report

    「The Group continues to work to further improve product quality in accordance with ISO 13485, the international standard for quality management of medical devices. However, there is no guarantee that its products will remain free of defects or that costs associated with product liability claims, recalls or other matters will not arise in the future.」

    While outlining its efforts to improve quality, the company reiterates the possibility of product defects, product liability claims and recalls.
  4. FY2016First statedAnnual report

    「The Group continues to work to further improve product quality in accordance with ISO 13485, the international standard for quality management of medical devices. However, there is no guarantee that its products will remain free of defects or that costs associated with product liability claims, recalls or other matters will not arise in the future.」

    While describing its efforts to improve quality, the company identifies the possibility of product defects, product liability claims and recall costs as risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Cyberdyne yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.